Håkan Mellstedt, MD, PhD, is professor of oncologic biotherapy at the Karolinska Institute and Cancer Centre Karolinska (CCK) at the Karolinska University Hospital in Stockholm, Sweden (1999-). He is Board Certified in Internal Medicine, Hematology and Oncology. . Professor Mellstedt was president of ESMO from 2004 to 2009 and chair of the ESMO Foundation from 2008 to 2012. Professor Mellstedt is the chair of the Swedish Childhood Cancer Foundation (2005-). He is member of the Accreditation Council of Oncology in Europe (ACOE) (2009-). Professor Mellstedt was awarded the Alfaferone Prize (Italy) 1989, the Jan Waldenström Award (USA) 2001, Cancer- and Allergy Foundation Award (Sweden) 2014. Professor Mellstedt has published about 500 manuscripts in peer-reviewed journals, is the author of numerous oncology chapters in professional medical textbooks, and has been an invited speaker at more than 225 international symposia. He is/has been on the editorial board of several international scientific journals. He holds several patents.
1) Immunobiology of B cell malignancies, as well as solid tumors
2) Development of biotherapeutics including cancer vaccines, monoclonal antibodies and cytokines in malignancies.
3) Development of tyrosine kinase inhibitors with a focus on ROR1.